Steven Cohen Bio Rad Laboratories, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 247,510 shares of BIO stock, worth $61.8 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
247,510
Previous 250,108
1.04%
Holding current value
$61.8 Million
Previous $83.7 Million
2.83%
% of portfolio
0.19%
Previous 0.23%
Shares
25 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
18.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$387 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$244 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$186 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$181 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.15B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...